Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2685

1.

Pharmacodynamics, safety, and immunogenicity of Pelmeg®, a pegfilgrastim biosimilar in healthy subjects.

Wessels H, Lehnick D, Höfler J, Jankowsky R, Chamberlain P, Roth K.

Pharmacol Res Perspect. 2019 Aug 13;7(5):e00507. doi: 10.1002/prp2.507. eCollection 2019 Oct.

2.

Pharmacokinetics, pharmacodynamics, safety, and immunogenicity of Pelmeg®, a pegfilgrastim biosimilar in healthy subjects.

Roth K, Lehnick D, Wessels H, Höfler J, Gastl B, Jankowsky R.

Pharmacol Res Perspect. 2019 Aug 13;7(5):e00503. doi: 10.1002/prp2.503. eCollection 2019 Oct.

3.

Clinical role of filgrastim in the management of patients at risk of prolonged severe neutropenia: an evidence-based review.

Bongiovanni A, Recine F, Fausti V, Rossi B, Mercatali L, Liverani C, De Vita A, Gurrieri L, De Bonis S, Miserocchi G, Spadazzi C, Calpona S, Riva N, Cocchi C, Ibrahim T.

Int J Clin Pract. 2019 Aug 13:e13404. doi: 10.1111/ijcp.13404. [Epub ahead of print] Review.

PMID:
31408256
4.

Biosimilars in oncology: A decade of experience with granulocyte colony-stimulating factor and its implications for monoclonal antibodies.

Krendyukov A, Schiestl M.

Crit Rev Oncol Hematol. 2019 Jul 23. pii: S1040-8428(18)30307-X. doi: 10.1016/j.critrevonc.2019.07.009. [Epub ahead of print] Review.

PMID:
31405784
5.

First Clinical Application of Polyurethane Meniscal Scaffolds with Mesenchymal Stem Cells and Assessment of Cartilage Quality with T2 Mapping at 12 Months.

Olivos-Meza A, Pérez Jiménez FJ, Granados-Montiel J, Landa-Solís C, Cortés González S, Jiménez Aroche CA, Valdez Chávez M, Renán León S, Gomez-Garcia R, Martínez-López V, Ortega-Sánchez C, Parra-Cid C, Velasquillo Martinez C, Ibarra C.

Cartilage. 2019 Aug 7:1947603519852415. doi: 10.1177/1947603519852415. [Epub ahead of print]

PMID:
31387368
6.

Safety and Relative Dose Intensity of Dose-dense Doxorubicin and Cyclophosphamide Followed by Dose-dense Paclitaxel.

Nishimura M, Onoe T, Sakai H, Arase M, Watanabe S, Soyama M, Hashimoto K, Miki M, Tane K, Hirokaga K, Takao S, Matsumoto K.

Anticancer Res. 2019 Aug;39(8):4379-4383. doi: 10.21873/anticanres.13607.

PMID:
31366533
7.

Delayed-onset effect of clofarabine in the treatment of an adult patient with acute myeloid leukemia.

Walchack R, Cumpston A, Vos J, Kanate AS.

Am J Health Syst Pharm. 2019 Feb 21;76(6):349-352. doi: 10.1093/ajhp/zxy055.

PMID:
31361841
8.

Hypoplastic acute myeloid leukemia in an elderly patient. A long-term partial remission with low-dose prednisone and G-CSF.

Islam A.

Clin Case Rep. 2019 May 17;7(7):1285-1290. doi: 10.1002/ccr3.2204. eCollection 2019 Jul.

9.

Granulocyte Colony Stimulating Factor in Burn Patients with Neutropenia.

Tabassum G, Khan I, Asif A, Shahzad I, Khalid FA, Tarar MN.

J Coll Physicians Surg Pak. 2019 Aug;29(8):706-709. doi: 10.29271/jcpsp.2019.08.706.

PMID:
31358087
10.

Promising role of filgrastim and α-tocopherol succinate in amelioration of gastrointestinal acute radiation syndrome (GI-ARS) in mice.

Gheita HA, El-Sabbagh WA, Abdelsalam RM, Attia AS, El-Ghazaly MA.

Naunyn Schmiedebergs Arch Pharmacol. 2019 Jul 27. doi: 10.1007/s00210-019-01702-6. [Epub ahead of print]

PMID:
31350581
11.

Propylthiouracil-induced agranulocytosis as a rare complication of antithyroid drugs in a patient with Graves' disease.

Rabelo PN, Rabelo PN, Paula AF, Conceição SAD, Viggiano DPPO, Antunes DE, Jatene EM, Paula SLFM, Dias ML, Reis MAL.

Rev Assoc Med Bras (1992). 2019 Jul 22;65(6):755-760. doi: 10.1590/1806-9282.65.6.755.

12.

Immunotherapy-induced severe neutropenia with neurotoxicity: A case of a 75-year-old woman with ulcerative colitis diagnosed with melanoma.

Patel R, Pai L.

J Oncol Pharm Pract. 2019 Jul 18:1078155219862341. doi: 10.1177/1078155219862341. [Epub ahead of print]

PMID:
31315551
13.

The Successful Sequential Use of Plerixafor and Eltrombopag For Hematopoietic Cell Transplantation in a Child With High-Risk Neuroblastoma.

Marjanska A, Czyzewski K, Debski R, Krenska A, Wysocki M, Styczynski J.

J Pediatr Hematol Oncol. 2019 Jul 12. doi: 10.1097/MPH.0000000000001551. [Epub ahead of print]

PMID:
31306338
14.

Preclinical evaluation of a biobetter candidate: Pharmacokinetics and pharmacodynamics of GX-G3 in healthy and neutropenia-induced rats.

Kim YJ, Ertan-Ahmed S, Capan Y, Yang SI.

Drug Dev Res. 2019 Jul 11. doi: 10.1002/ddr.21563. [Epub ahead of print]

PMID:
31294492
15.

Isolated neutropenia as a rare but serious adverse event secondary to immune checkpoint inhibition.

Naqash AR, Appah E, Yang LV, Muzaffar M, Marie MA, Mccallen JD, Macherla S, Liles D, Walker PR.

J Immunother Cancer. 2019 Jul 5;7(1):169. doi: 10.1186/s40425-019-0648-3.

16.

A Phase 2, International, Multicenter, Open-label Clinical Trial of Subcutaneous Tbo-Filgrastim in Pediatric Patients With Solid Tumors Undergoing Myelosuppressive Chemotherapy.

Federman N, Dragomir MD, Kizyma Z, Roganovic J, Bias P, Lammerich A, Ben Arie ZR, Zou L, Hoehn G, Buchner A.

J Pediatr Hematol Oncol. 2019 Jul 3. doi: 10.1097/MPH.0000000000001542. [Epub ahead of print]

PMID:
31274668
17.
18.

Drug safety surveillance within a strategy for the management of non-chemotherapy drug-induced neutropenia.

Revuelta-Herrero JL, García-Sánchez R, Anguita-Velasco J, de Lorenzo-Pinto A, Ortega-Navarro C, Sanjurjo-Sáez M.

Int J Clin Pharm. 2019 Jun 29. doi: 10.1007/s11096-019-00873-9. [Epub ahead of print]

PMID:
31256332
19.

Targeting Financial Toxicity in Oncology Specialty Pharmacy at a Large Tertiary Academic Medical Center.

Farano JL, Kandah HM.

J Manag Care Spec Pharm. 2019 Jul;25(7):765-769. doi: 10.18553/jmcp.2019.25.7.765.

20.

Immune profiling in diffuse large B-cell lymphoma and mantle cell lymphoma patients treated with autologous hematopoietic cell transplant.

Herr MM, Torka P, Zhang Y, Wallace PK, Tario JD Jr, Repasky EA, Chen GL, Ho CM, Balderman SR, Ross M, Paiva B, Hernandez-Ilizaliturri FJ, McCarthy PL, Hahn T.

Bone Marrow Transplant. 2019 Jun 21. doi: 10.1038/s41409-019-0591-4. [Epub ahead of print]

PMID:
31227776

Supplemental Content

Loading ...
Support Center